Free Trial

ADC Therapeutics (ADCT) SEC Filings & 10K Form

ADC Therapeutics logo
$2.42 +0.19 (+8.30%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$2.38 -0.04 (-1.45%)
As of 05/23/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ADC Therapeutics SEC Filings

DateFilerForm TypeView
05/19/2025
6:40 PM
ADC Therapeutics (Subject)
HPWH TH AG (Filed by)
Form SCHEDULE 13G/A
05/14/2025
7:14 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:14 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
9:50 AM
ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/21/2025
8:20 AM
ADC Therapeutics (Filer)
Form DEFA14A
04/21/2025
8:20 AM
ADC Therapeutics (Filer)
Form DEF 14A
04/09/2025
11:07 AM
ADC Therapeutics (Filer)
Form PRE 14A
03/27/2025
2:28 PM
ADC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2025
2:34 PM
ADC Therapeutics (Filer)
Form ARS
03/27/2025
6:39 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:20 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:21 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:22 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:22 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:23 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:10 PM
ADC Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G
01/13/2025
11:20 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:37 PM
ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:39 PM
ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:42 PM
ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:35 PM
ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:30 PM
ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
8:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/13/2024
3:13 PM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
7:58 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/13/2024
7:30 AM
ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/07/2024
9:44 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:54 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:35 PM
ADC Therapeutics (Filer)
Form DEF 14A
09/23/2024
3:39 PM
ADC Therapeutics (Filer)
Form DEFA14A
08/13/2024
11:15 PM
ADC Therapeutics (Filer)
Form EFFECT
08/06/2024
3:26 PM
ADC Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
9:06 AM
ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:37 AM
ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
7:00 PM
ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:40 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:41 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:43 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:45 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
06/18/2024
8:29 PM
ADC Therapeutics (Subject)
Azelby Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:30 PM
ADC Therapeutics (Subject)
Squarer Ron (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:35 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:37 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:38 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
ADC Therapeutics (Subject)
BIZZARI JEAN-PIERRE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:28 PM
ADC Therapeutics (Subject)
Sandor Victor (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:44 PM
ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:46 PM
ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:37 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM
ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:23 PM
ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:25 PM
ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:29 PM
ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
2:33 PM
ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ADCT) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners